| Molecular Formula | C10H19NO4 |
| Molar Mass | 217.26 |
| Density | 1.118±0.06 g/cm3(Predicted) |
| Boling Point | 320.7±27.0 °C(Predicted) |
| Flash Point | 147.8°C |
| Solubility | Dichloromethane, Ether, Ethyl Acetate, |
| Vapor Presure | 2.53E-05mmHg at 25°C |
| Appearance | Oil |
| Color | Colourless |
| pKa | 14.36±0.10(Predicted) |
| Storage Condition | 2-8°C |
| Refractive Index | 1.474 |
| MDL | MFCD03426270 |
| Hazard Class | IRRITANT |
| introduction | 4-Boc-2-hydroxymethylmorpholine is a pharmaceutical intermediate, which can be obtained by using 4-Boc-2-hydroxymethylmorpholine as raw material. It has been reported that it can be used to prepare compounds that inhibit the activity of Bcl-2 anti-apoptotic proteins. |
| Preparation | 4-Boc-2-hydroxymethylmorpholine can be made of 4-Boc-2-hydroxymethylmorpholine as raw material, through two The step preparation is obtained. |
| application example | 4-Boc-2-hydroxymethylmorphine can be used to prepare compound 2-(1H-pyrrolo [2,3-b] pyridine-5-yloxy)-4-(1-(2-(4-chlorophenyl)-4, 4-Dimethylcyclohexyl-1-enyl) methyl)-1,2,3, 6-tetrahydropyridine-4-yl)-N-(4-((4-(2-(dimethylamine) acetyl) morpholin-2-yl) methylamine)-3-nitrobenzenesulfonyl) benzamide. These compounds are compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins, and can be used to treat diseases related to the expression of anti-apoptotic Bcl-2 proteins. |